Australia's Bioxyne jumps on entering German market with $3.7 mln deal
** Bioxyne BXN.AX jumps as much as 16.1% to A$0.036, highest since February 28 ** Pharmaceutical co enters German cannabis market with 3.2 mln-euro ($3.7 mln) manufacture and supply agreement ** Around 4.2 mln shares traded vs 30-day avg of 3.6 mln ** BXN last up 12.9%, takes YTD gains to 29.6% ($1 = 0.8703 euros) (Reporting by Shivangi Lahiri in Bengaluru) ((shivangi.lahiri@thomsonreuters.com))
Recent news on BLS Pharmaceuticals
See all newsBrief: BLS Pharmaceuticals Posts Q1 FY27 Revenue A$26.7M
Brief: BLS Pharmaceuticals Reports Record Q1 FY27 Revenue Of A$26.7 Million
Australia's BLS Pharmaceuticals extends gains on upbeat outlook, strong results
Brief: BLS Pharmaceuticals Sees FY27 Adjusted. EBITDA Margin 23% - 26%
Brief: BLS Pharmaceuticals Posts FY Net Profit After Tax Of A$15.4 MLN